Effects of cigarette smoke and 3-methylcholanthrene on the disposition of phencyclidine and its N-ethylamine analogue in the isolated perfused lung of rats

The isolated perfused lung (IPL) of rats were used to examine the pulmonary disposition and metabolism of radiolabeled phencyclidine (PCP) and N-ethyl-1-phenylcyclohexylamine (PCE). The IPL removed PCP and PCE from the perfusate and converted them to free and conjugated metabolites. At the conclusion of a 1-h perfusion, the lung accumulated at least 20% of the administered radioactivity and metabolized more than 30% of the added drug. Pretreatment of rats with 3-MC or cigarette smoke enhanced significantly PCP and PCE metabolism by the IPL. The concentration of conjugated PCE metabolite in the perfusate of the IPL was increased significantly by both 3-MC and cigarette smoke pretreatments whereas the concentration of conjugated PCP metabolite was not affected by cigarette smoke exposure and increased only slightly after 3-MC pretreatment. Pretreatment of rats with 3-MC or cigarette smoke also altered the amount of radioactivity accumulated by the lung tissue at the conclusion of a 1-h perfusion. Inasmuch as PCP and PCE are often abused by humans via smoke inhalation, a significant amount of these drugs may be stored or metabolized by the lung.

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

We constructed a plasmid coexpression vector that directs the insertion of a foreign gene of interest together with the Escherichia coli beta-galactosidase (beta gal) gene into the thymidine kinase (TK) locus of the vaccinia virus genome. Tissue culture cells that had been infected with vaccinia virus were transfected with a plasmid vector containing a foreign gene. TK- recombinants could be selected by a plaque assay on TK- cells in the presence of 5-bromodeoxyuridine and distinguished from spontaneous TK- mutants by the addition of a beta-gal indicator to the agarose overlay. Plaques that expressed beta-gal stained dark blue within several hours at 37 degrees C. Alternatively, TK- selection could be eliminated, and recombinant plaques could be readily identified solely by their blue color. The reverse procedure, in which the starting virus expresses beta-gal (i.e., forms blue plaques) and the desired recombinant has deleted the entire beta-gal gene (i.e., forms white plaques), is another alternative. Each protocol was tested by constructing vaccinia virus recombinants that express hepatitis B virus surface antigen.

The BB-rat--an authentic model of human diabetic retinopathy

The pathogenesis of diabetic retinopathy has not been fully explained. The earliest histological lesion is the loss of intramural pericytes and thickening of the basement membrane. Increased activity of the polyol pathway is a probable mechanism for these two abnormalities. Investigations have suffered from the lack of an exact animal model simulating the human condition. Examination of the retina in the spontaneously diabetic BB-rat demonstrated degeneration and loss of intramural pericytes, a progressive increase in basement membrane thickness, and microinfarctions with areas of non-perfusion. Therefore, this model may be used to clarify the biochemical mechanism(s) linking the metabolic abnormalities of diabetes and the retinopathy.

Recombination and deletion of sequences in shuttle vector plasmids in mammalian cells

Shuttle vector plasmids were constructed with directly repeated sequences flanking a marker gene. African green monkey kidney (AGMK) cells were infected with the constructions, and after a period of replication, the progeny plasmids were recovered and introduced into bacteria. Those colonies with plasmids that had lost the marker gene were identified, and the individual plasmids were purified and characterized by restriction enzyme digestion. Recombination between the repeated elements generated a plasmid with a precise deletion and a characteristic restriction pattern, which distinguished the recombined molecules from those with other defects in the marker gene. Recombination among the following different sequences was measured in this assay: (i) the simian virus 40 origin and enhancer region, (ii) the AGMK Alu sequence, and (iii) a sequence from plasmid pBR322. Similar frequencies of recombination among these sequences were found. Recombination occurred more frequently in Cos1 cells than in CV1 cells. In these experiments, the plasmid population with defective marker genes consisted of the recombined molecules and of the spontaneous deletion-insertion mutants described earlier. The frequency of the latter class was unaffected by the presence of the option for recombination represented by the direct repeats. Both recombination and deletion-insertion mutagenesis were stimulated by double-strand cleavage between the repeated sequences and adjacent to the marker, and the frequency of the deletion-insertion mutants in this experiment was again independent of the presence of the direct repeats. We concluded that although recombination and deletion-insertion mutagenesis were both stimulated by double-strand cleavage, the molecules which underwent the two types of change were drawn from separate pools.

Influence of simultaneous exposure to acrylonitrile and styrene on the toxicity and metabolism of styrene in rats

Nine groups of adult male rats were given different combinations of styrene and acrylonitrile and each chemical was administered at three doses (styrene 0, 5.8, and 11.6 mmol/kg, ip; acrylonitrile 0, 0.3, and 0.6 mmol/kg, po). The animals were killed 24 hr later and blood and urine samples were collected. The results of biochemical analyses due to the toxicity of both chemicals and of the determination of urinary metabolites of styrene were then subjected to a factorial (3 X 3) analysis of variance. There was: (1) a significant elevation of blood urea nitrogen (BUN) and serum glutamic-pyruvic transaminase (SGPT), and a diminution of urinary creatinine due to styrene; (2) an increase in serum creatinine and serum glutamicoxaloacetic transaminase (SGOT) due to styrene that was further increased by acrylonitrile; and (3) an increase in the concentrations of urinary metabolites (thioethers, mandelic, phenylglyoxylic, and hippuric acids) due to styrene that was considerably reduced by acrylonitrile. These results suggest that styrene causes renal toxicity which may be potentiated by acrylonitrile; furthermore, the significant diminution of the urinary metabolites of styrene due to acrylonitrile obscures interpretation of the results of the biological monitoring of exposure to styrene.

Lipid peroxidation in developing rat brain during undernutrition

The effect of undernutrition has been studied in relation to lipid peroxidation, both in vitro and in vivo, in the brain of developing rats. Lipid peroxidation in brain homogenates as well as in the mitochondrial fraction of brain was significantly higher in undernourished groups than in controls. This difference was maximal at the 12th postnatal day. Following rehabilitation for two weeks, this increased lipid peroxidation in brains of undernourished rats could no longer be observed. Determination of malonaldehyde levels in vivo did not show an appreciable difference between control and undernourished animals.

Survival and mutagenesis of bacterial plasmids with localized carcinogen adducts

Restriction fragments from nonessential gene regions in bacterial plasmids were covalently modified with benzo[a]pyrene-7,8-dihydrodiol-9,10-oxide (BPDE) and ligated to the remaining unmodified fragment to construct the plasmid with a localized patch of BPDE adducts. These preparations were introduced into appropriate strains of E. coli and the effect of the carcinogen adducts on plasmid survival and mutagenesis determined. Survival as a function of adduct concentration of randomly modified plasmids was the same as that of plasmids with localized adducts in both repair-proficient and -deficient strains, indicating that the simple presence of the carcinogen is the main factor in plasmid mortality. The results of these and other experiments indicate that plasmid survival is a function of the adduct/plasmid molecule ratio not the adduct/nucleotide ratio. Plasmids with mutations produced in the region (tetracycline resistance) containing the localized adducts were selected and the nature of the mutations determined by direct sequence analysis. The mutations included frameshifts, transitions, and transversions.

Chromosome analysis of Dalton's lymphoma adapted to the Swiss mouse: clonal evaluation and C-heterochromatin distribution

Chromosome studies of Dalton's lymphoma, which was originally developed in the DBA/2 mouse and later adapted to a close inbred strain of the Swiss albino mouse, revealed only one rb-marker in all cells bearing a modal number (71). After several successive in vivo passages of the tumor, a new cell clone appeared with a different modal number (70) and two rb-markers. This new cell clone gradually outnumbered the stem cells and an apparent enhancement in tumorigenicity was noted. C-banding of the new cell clone revealed that one of the two telomeric heterochromatin-bearing chromosomes, originally present in the stem cells, had been involved in a Robertsonian fusion to form the additional marker chromosome. G-banded analysis indicated the noninvolvement of chromosome #15 in the fusion.

Mutagenesis of a shuttle vector plasmid in mammalian cells

Recently we and others have reported a high frequency of mutagenesis of shuttle vector plasmids after passage in mammalian cells (Razzaque et al., Proc. Natl. Acad. Sci. U.S.A. 80:3010-3014, 1983; Calos et al., Proc. Natl. Acad. Sci. U.S.A. 80:3015-3019, 1983). The mutation frequency was determined by monitoring the integrity of a bacterial marker gene on the plasmid by standard microbiological procedures. Mutant plasmids contained deletions, insertions of cell DNA, and point mutations. The observed mutation frequency of 1% is much higher than that of cellular markers and could be due to the induction of a mutagenic environment by infection with a replicating plasmid. Alternatively, the hypermutagenesis may be due to some critical transient or persistent difference between the DNA in the plasmid and the cellular chromosome. We performed a number of experiments designed to distinguish between these alternatives, with particular reference to deletion mutagenesis. We conclude that mutagenesis was specific to the plasmid and propose that the majority of the deletion and insertion mutants were generated very early in the infection, before replication of the vector. However, some deletion mutagenesis also occurred after plasmid replication had begun.

Increased activity of certain hepatic drug-metabolizing enzymes due to subchronic exposure to bromobenzene

Male Sprague-Dawley rats were treated i.p. with different doses of bromobenzene (0, 0.1, 0.2, 0.3 and 0.5 mmol/kg) in corn oil for 4 weeks. The animals were killed 24 h after the end of the treatment for hepatic drug metabolism studies. A significant induction of the activities of microsomal aniline hydroxylase (51%) and aminopyrine N-demethylase (58%) was observed at 0.5 mmol/kg dose level. Liver microsomal cytochrome P-450 content was significantly increased (approx. 38%) at subchronic doses of 0.3 and 0.5 mmol/kg. Hepatic glutathione (GSH) concentrations were increased (approx. 30%) in comparison to control values at subchronic doses of 0.3 and 0.5 mmol/kg, whereas a significant induction (46-72%) of the activities of conjugating enzymes, cytosolic glutathione S-transferases was noticed at any subchronic dose level of bromobenzene studied. These results suggest that, under certain conditions, subchronic pretreatment with bromobenzene may have the potential to modify the acute toxicity of its own as well as those of other environmental pollutants which require metabolic activation.

Dose-dependent metabolic excretion of bromobenzene and its possible relationship to hepatotoxicity in rats

Male Sprague-Dawley rats received an intraperitoneal injection of 0.25-, 0.5-, 1.0-, 2.5-, and 5.0-mmol/kg dose of bromobenzene in corn oil. The metabolic fate of bromobenzene was studied by measuring its various urinary metabolites 24 h following bromobenzene administration. The hepatotoxicity of bromobenzene was estimated by determination of the serum glutamic-oxaloacetic and glutamic-pyruvic transaminase activities (SGOT and SGPT) 24 h after dosing. Treatment of rats with bromobenzene at up to 0.5 mmol/kg did not influence the transaminase activities, but significant increases in such activities began to manifest at a dose of 1 mmol/kg. However, no further increase in hepatotoxic response was induced on exposure to higher doses (2.5 and 5.0 mmol/kg) of bromobenzene. The urinary excretion of toxic doses of bromobenzene was nonlinear, based on the quantitative composition of various urinary metabolites. Furthermore, the fraction of the dose converted to thioethers, p-bromophenol, m-bromophenol, and total phenolic metabolites decreased with increasing toxic dose, suggesting their formation to be capacity-limited. The ratios of thioethers to total phenolic metabolites, of thioethers to p-bromophenol, and of thioethers to o-bromophenol decreased with increasing dose of bromobenzene. The correlation of the dose-dependent fate of metabolic excretion of bromobenzene with the results of the dose-hepatotoxic response curves supports the conclusion that there exists an apparent threshold dose (approximately 1-2.5 mmol/kg) for the toxic effects of bromobenzene that coincides with saturation of the metabolic pathways involving both glutathione/glutathione S-transferase(s) and formation of certain phenolic derivatives for its detoxification. All these results further suggest a role of a saturable, metabolic activation process involving 3,4-epoxide rather than 2,3-epoxide of bromobenzene in the development of its hepatotoxicity.

Effects of drug and chemical pretreatments on biliary excretion of phenylcyclohexene in the rat

The biliary excretion of 14C-phenylcyclohexene and its metabolites were studied in rats pretreated with an inducer or inhibitor of mixed-function oxidases or with an agent known to deplete liver glutathione. Pretreatment of rats with 3-methylcholanthrene or phenobarbital enhanced the biliary excretion of 14C-phenylcyclohexene and/or its metabolites. Conversely, pretreatment of rats with SKF-525A or piperonyl butoxide decreased the biliary excretion of 14C-phenylcyclohexene and/or its metabolites. In contrast, pretreatment of rats with diethylmaleate did not alter significantly the rate of biliary excretion of radioactivity.

Temporal distinction between repair and mutagenesis of benzopyrene adducts after SOS induction in Escherichia coli

Plasmid DNA covalently modified with benzopyrene diol epoxide was introduced into Escherichia coli strains which differed in their capacity for repair and mutagenesis at various times after SOS induction. The uvrA+-dependent repair activity rose and fell before umuC+SOS-dependent mutagenesis was fully expressed.

The dispositional kinetics of phencyclidine and its N-ethylamine analogue in rats

The uptake kinetics of [3H]-labelled phencyclidine (PCP) and N-ethyl-l-phenycyclohexylamine (PCE) in rats, measured in terms of decreases in the blood concentrations of the drugs after i.v. administration of a single 1.09 mumol dose, were not significantly different. Within a week of administration, the rats excreted about 93% of the [3H]-PCP and about 65% of [3H]-PCE via their urine and faeces; their urine contained nore [3H], mainly as metabolites of [3H]-PCP and of [3H]-PCE, than their faeces. Similarly, more [3H] remained in the tissues of rats treated with [3H]-PCE than in the tissues of [3H4-PCP-treated rats. The fact that PCE is metabolized and excreted more slowly than PCP may account for the higher psychotropic effects of PCE.

Disposition and metabolism of diphenyl ether in rats

After i.p. administration of [14C]diphenyl ether (5 mg/kg) to rats, radioactivity was detected rapidly in all organs and tissues. After intragastric administration of [14C]diphenyl ether (10 mg/kg) to rats, unchanged diphenyl ether in the blood was at max. concn. within 15 h and decreased linearly with time, with a biological half-life of about 1.5 h. More than 90% of the intragastrically administered dose was excreted in urine and faeces within three days; greater than 80% dose was in the urine. From g.l.c. and mass-spectral data, it was shown that rats metabolized diphenyl ether to its 2-hydroxy, 4-hydroxy, 4,4'-dihydroxy, 4-methoxy-monohydroxy and 4-methoxy-dihydroxy derivatives.

The nephrotoxic potential of styrene in Sprague-Dawley rats

Pre-fasted (16 h) Sprague-Dawley male rats were treated i.p. with 0, 0.2, 0.4, 0.8 and 1.2 g/kg of styrene in corn oil. Renal functions were assessed at 0-24, 24-48 and 48-72 h after the exposure. Urinary creatinine was decreased at 0.8 g/kg of styrene during 0-24 h after the treatment compared to control, whereas such a decrease was noticed in 1.2 g/kg styrene-treated rats when compared to control groups during 0-24 and 0-48 h after the dose. Urine pH and urinary contents of sodium, potassium and chloride were all decreased in a dose-dependent manner at 0.8 and 1.2 g/kg of styrene compared to both control animals during 0-24 h, whereas urinary proteins were not affected significantly. In another experiment, groups of pre-fasted (16 h) rats were treated i.p. with 0, 0.8 and 1.2 g/kg of styrene in corn oil and were then fasted for another 24 h to induce more stress prior to collection of blood and urine. Urinary pH and excretions of sodium and potassium were all decreased in styrene-treated rats 24 h after the dose. Urinary proteins were elevated and relative kidney weights were increased in 1.2 g/kg styrene-treated rats only compared to both control and 0.8 g/kg styrene-treated groups. A significant increase in serum creatinine and an increase close to significant in blood urea nitrogen were observed at 1.2 g/kg dose. These results suggest an impairment of renal functional parameters due to acute styrene exposure and further demonstrate a possible dose-dependent nephrotoxic potential of styrene in rats.

Biological properties of acmycin, a new polyene antibiotic

Acmycin, a new polyene antibiotic, was fungistatic at low and fungicidal at high concentrations. It produced malformations in conidia of Helminthosporium oryzae and Curvularia lunata and caused leakage of yeast cells. Acmycin was fairly nontoxic to germinating seeds. The intravenous LD50 was 300-400 and intraperitoneal maximum tolerated dose 100-500 mg/kg body mass of mice.

Metabolic disposition and irreversible binding of 1-phenylcyclohexene in rats

The metabolic disposition of 1-[14C]phenylcyclohexene ([14C]PC) was examined in rats after ip or iv drug administration. Radioactivity, which was accumulated by various organs, peaked within 30 min after ip administration of [14C]PC (0.21 mg/kg). A significant amount of this radioactivity was not extractable by repeated methanol extractions, indicating irreversible binding of [14C]PC metabolite(s) to tissue proteins. Following iv administration of [14C]PC (0.42 mg/kg), [14C]PC concentrations in blood declined biphasically with time; the blood elimination half-life of [14C]PC is 77 min. About 83% of the dose given was excreted in urine and feces within 54 hr of administration. About 35% of the dose was excreted in the bile in 1 hr. At least four [14C]PC metabolites were detected in the urine or bile. The bulk of the urinary radioactivity was composed of metabolites since less than 6% of [14C]PC given was excreted unchanged in the urine.